Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Young researcher from UFS on SAYAS executive committee
2014-10-28



Dr Aliza le Roux
Photo: Sonia Small
Dr Aliza le Roux from the Department of Zoology and Entomology on the UFS’s Qwaqwa Campus is one of ten young scientists who was recently inaugurated as a new member of the South African Young Academy of Science (SAYAS). Not only was she inducted into the society this past October, but she was also elected to serve on the executive committee for SAYAS.

Dr Le Roux’s research focus is on cognitive ecology, behavioural ecology and zoology. She has expressed her excitement about the new position, and is already developing new ideas with her new colleagues on drawing more young people into the South African scientific community.

This position provides a regional and international platform to raise the profile of science in general, and Le Roux hopes to be active in SAYAS’s new mentorship collaboration with the New York Academy of Sciences, and to introduce new methods of scientific outreach using social media. Inspired by the students on the Qwaqwa Campus, Dr Le Roux hopes to specifically target relatively isolated rural campuses in SAYAS’s activities.

Prof Corli Witthuhn, Vice-Rector: Research at the UFS, said, “Aliza le Roux is an outstanding young scientist on our Qwaqwa Campus. I am very excited about the young researchers on our Qwaqwa Campus with Aliza as one of the leaders, and I am looking forward to what else they can achieve in the next five years.”

SAYAS was launched in October 2011 with 20 founding members as a mechanism to propel South Africa’s young scientists to fully participate in relevant local and international research and development agendas. It provides a national platform where leading young scholars from all disciplines in the country can interact, and also access international networking and career development opportunities.

SAYAS contributes primarily to the achievement of the national strategic priority of strengthening the skills and human-resource base of the country. Its particular niche is to focus on strengthening high-level skills among young scientists and the promotion of scientific excellence.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept